In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

However, on the same day, Deutsche Bank maintained a Buy rating on GlaxoSmithKline (LSE: GSK). GSK market cap is currently £55.9B and has a P/E ratio of 22.22. Based on the recent corporate insider ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology market and expanding its preventive healthcare through adult vaccines.

As on Nov 08, 2024, Glaxosmithkline Pharmaceuticals Ltd (GLAXO)’s share price on NSE is Rs 2561.15 What is the market cap of Glaxosmithkline Pharmaceuticals Ltd (GLAXO?) The current market ...

GlaxoSmithKline said its key brands held their market share and continued to stay in line with the respective category performance. GlaxoSmithKline Pharmaceuticals on October 29 reported a 16 ...

BMI has predicted that naira will reach N1,993/$ by 2028, impacting Nigeria’s pharmaceutical industry’s ability to import ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

Davis and Feinberg are also buying global leaders, such as insurance giant AIG, because overseas markets are generally growing faster than the U.S. market. Their formula works: Over the past ...

For further results highlights, click. GlaxoSmithKline Pharma continued to benefit from rising market share for its antibiotic Augmentin and respiratory drugs Nucala and Trelegy. Moreover ...

Nigerians are bracing for more economic weakness after the local currency ... However, the Nigerian naira is still not ...